"The Community Cancer Center is a joint venture between two local hospitals, OSF Healthcare and Advocate Bromenn. In the late 1990’s both hospitals came together to create the facility in order to ensure state of the art technology and high quality cancer care in the community for the future. Our physicians and staff specialize in the treatment of numerous types of cancer, including complex and advanced stage cases. We are Central Illinois’ leader in cancer care."

During the past decade, Community Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 157 clinical trials were completed, i.e. on average, 2242.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 37 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 90 trials, followed by "National Cancer Institute (NCI)" with 61 trials sponsored, "SWOG Cancer Research Network" with 25 trials sponsored, "Eastern Cooperative Oncology Group" with 14 trials sponsored and "Radiation Therapy Oncology Group" with 14 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 170 trials as a collaborator, "NCIC Clinical Trials Group" with 16 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator and "Eastern Cooperative Oncology Group" with 12 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Community Cancer Center" are "Breast Cancer" (39 trials), "Lung Cancer" (22 trials), "Lymphoma" (18 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Leukemia" (10 trials). Many other conditions were trialed in "Community Cancer Center" in a lesser frequency.

Most popular intervention types in "Community Cancer Center" are "Drug" (195 trials), "Other" (101 trials), "Biological" (84 trials), "Radiation" (46 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "placebo" (33 trials), "Quality-of-Life Assessment" (18 trials), "carboplatin" (18 trials) and "Bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Community Cancer Center" are 181 trials for "All" genders, 44 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Community Cancer Center". undefined are not yet recruiting, undefined are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 166 completed trials in Community Cancer Center, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Community Cancer Center, 15 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 111 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".